Gilead Sciences (GILD) Cash & Current Investments (2009 - 2026)
Gilead Sciences posted quarterly Cash & Current Investments of $7.6 billion for Q1 2026, down 3.57% year-on-year from $7.9 billion in Q1 2025, and little changed on a QoQ basis from $7.6 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Cash & Current Investments data on file, last reported at $7.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 3.57% year-over-year to $7.6 billion; the trailing twelve-month figure through Mar 2026 stood at $7.6 billion (down 3.57% YoY), and the FY2025 full-year result was $7.6 billion, down 23.61% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $7.6 billion, roughly flat from $7.6 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $10.0 billion in Q4 2024 and bottomed at $2.8 billion in Q2 2024.
- The 5-year median for Cash & Current Investments is $6.4 billion (2022), against an average of $6.4 billion.
- The widest annual swing landed in 2024, when Cash & Current Investments sank 58.42%; it then surged 88.06% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $6.4 billion in 2022, then climbed by 13.77% to $7.3 billion in 2023, then jumped by 37.54% to $10.0 billion in 2024, then slipped by 23.61% to $7.6 billion in 2025, then grew by 0.14% to $7.6 billion in 2026.
- The last three Cash & Current Investments figures came in at $7.6 billion (Q1 2026), $7.6 billion (Q4 2025), and $7.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64 Bn |
| Dec 31, 2025 | 7.63 Bn |
| Sep 30, 2025 | 7.35 Bn |
| Jun 30, 2025 | 5.21 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 9.99 Bn |
| Sep 30, 2024 | 5.04 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 4.72 Bn |
| Dec 31, 2023 | 7.26 Bn |
| Sep 30, 2023 | 6.86 Bn |
| Jun 30, 2023 | 6.67 Bn |
| Mar 31, 2023 | 5.87 Bn |
| Dec 31, 2022 | 6.39 Bn |
| Sep 30, 2022 | 5.66 Bn |
| Jun 30, 2022 | 5.66 Bn |
| Mar 31, 2022 | 5.33 Bn |
| Dec 31, 2021 | 6.52 Bn |
| Sep 30, 2021 | 5.74 Bn |
| Jun 30, 2021 | 6.53 Bn |
| Mar 31, 2021 | 5.67 Bn |
| Dec 31, 2020 | 7.41 Bn |
| Sep 30, 2020 | 23.98 Bn |
| Jun 30, 2020 | 18.91 Bn |
| Mar 31, 2020 | 20.79 Bn |
| Dec 31, 2019 | 24.35 Bn |
| Sep 30, 2019 | 22.86 Bn |
| Jun 30, 2019 | 27.18 Bn |
| Mar 31, 2019 | 27.90 Bn |
| Dec 31, 2018 | 30.09 Bn |
| Sep 30, 2018 | 28.47 Bn |
| Jun 30, 2018 | 25.92 Bn |
| Mar 31, 2018 | 24.00 Bn |
| Dec 31, 2017 | 25.51 Bn |
| Sep 30, 2017 | 28.39 Bn |
| Jun 30, 2017 | 21.10 Bn |
| Mar 31, 2017 | 14.12 Bn |
| Dec 31, 2016 | 11.90 Bn |
| Sep 30, 2016 | 12.27 Bn |
| Jun 30, 2016 | 8.75 Bn |
| Mar 31, 2016 | 8.32 Bn |
| Dec 31, 2015 | 14.61 Bn |
| Sep 30, 2015 | 15.71 Bn |
| Jun 30, 2015 | 8.61 Bn |
| Mar 31, 2015 | 11.29 Bn |
| Dec 31, 2014 | 10.13 Bn |
| Sep 30, 2014 | 6.32 Bn |
| Jun 30, 2014 | 8.80 Bn |
| Mar 31, 2014 | 6.47 Bn |
| Dec 31, 2013 | 2.13 Bn |
| Sep 30, 2013 | 2.09 Bn |
| Jun 30, 2013 | 2.29 Bn |
| Mar 31, 2013 | 1.94 Bn |
| Dec 31, 2012 | 1.86 Bn |
| Sep 30, 2012 | 1.70 Bn |
| Jun 30, 2012 | 1.71 Bn |
| Mar 31, 2012 | 1.45 Bn |
| Dec 31, 2011 | 9.90 Bn |
| Sep 30, 2011 | 2.26 Bn |
| Jun 30, 2011 | 2.27 Bn |
| Mar 31, 2011 | 3.01 Bn |
| Dec 31, 2010 | 2.10 Bn |
| Sep 30, 2010 | 2.31 Bn |
| Jun 30, 2010 | 1.48 Bn |
| Mar 31, 2010 | 1.65 Bn |
| Dec 31, 2009 | 1.66 Bn |
| Sep 30, 2009 | 1.36 Bn |
| Jun 30, 2009 | 1.24 Bn |
| Mar 31, 2009 | 1.66 Bn |